GRM5 and early-onset autosomal dominant Alzheimer disease: In particular, mGluR5 seems to be a receptor of the neurotoxic amyloid-β42 peptide, and genetic deletion of mGluR5 interfered with the progression of amyloid deposition and mTOR phosphorylation and rescued cognitive impairment in a mouse model of Alzheimer’s disease [119].